Health Care Sector Update for 02/28/2018: HTBX, SGYP, CODX, GILD

Shutterstock photo

Top Health care stocks:

JNJ: +0.3%

PFE: +0.5%

ABT: flat

MRK: +0.4%

AMGN: +0.3%

Health care shares were higher ahead of the bell on Wednesday.

Expected movers:

- Heat Biologics ( HTBX ) said interim results from a phase 2 study showed partial response and disease control in lung cancer patients treated with a drug combination including its HS-110

- Synergy Pharmaceuticals ( SGYP ) said Cipher Pharmaceuticals acquired the exclusive Canadian rights to develop, market, distribute, and sell Synergy's Trulance, which was developed for the treatment of chronic idiopathic constipation

- Co-Diagnostics ( CODX ) said that ongoing research and development activities yielded "positive" results in demonstrating the capabilities of co-primers in multiplex tests for SNP detection

Other news:

- Gilead Sciences ( GILD ) said its EPCLUSA has been included in Ontario's expansion of access to Hepatitis C treatments eligible for coverage under the Province's drug benefit program

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , US Markets
Referenced Symbols: HTBX , CODX , GILD

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?